Cover Image

Assessment of generic medicines development and entry decisions by the malaysian generic pharmaceutical industries

Saved in:

Bibliographic Details
Main Authors:	Omotayo Fatokun (Author), Mohamed Izham Mohamed Ibrahim (Author), Mohamed Azmi Hassali (Author)
Format:	Book
Published:	Archives of Global Professionals, 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving generic medicines use in transition economies
by: Mohamed Azmi Ahmad Hassali
Published: (2015)

Knowledge and perception of senior year pharmacy students about generic medicines in public Universities of Malaysia
by: Shi Wei Lee, et al.
Published: (2014)

Assessment of Knowledge, Attitudes, and Factors Influencing the Selection Student of Generic Medicine
by: Mohamed N. Al-Arifi
Published: (2021)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
by: Wei Zhang, et al.
Published: (2022)

The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013-2020
by: Sunand Kannappan, et al.
Published: (2021)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
by: Bregtje W. Kamphuis, et al.
Published: (2021)

Patients' beliefs about generic medicines in Malaysia
by: Wong ZY, et al.
Published: (2014)

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines
by: Dong‐Sook Kim, et al.
Published: (2022)

The development and validation of a generic instrument, QoDoS, for assessing the quality of decision making
by: Ronan Donelan, et al.
Published: (2016)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Amir Hashemi-Meshkini, et al.
Published: (2014)

Development and assessment of generic competences on bachelor degree
by: Jorge Enrique Pérez Martínez, et al.
Published: (2013)

A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia
by: Al-Gedadi NA, et al.
Published: (2008)

Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
by: Lamia Al Ali, et al.
Published: (2022)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
by: Muhammad M. Hammami, et al.
Published: (2017)

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
by: Susan Spillane, et al.
Published: (2015)

Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE
by: Mohamed Naser Farghaly, et al.
Published: (2021)

Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
by: Garth Boehm, et al.
Published: (2013)

GENERIC MEDICINES AND THE SUSTAINABILITY OF THE NATIONAL HEALTH SYSTEM
by: Rui Peres Alves, et al.
Published: (2011)

Value of generic medicines: an health economics study
by: Martin Albrecht, et al.
Published: (2015)

Pharmaceutical development with commercialization of generic drugs with poor soluble substance - tablets of drug nimodipine
by: O. E. Schykovskiy, et al.
Published: (2018)

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C
by: Heath K
Published: (2018)

Development and assessment of generic competences in engineering degrees through creativity
by: Diego Anguís
Published: (2012)

Generic Drugs or Branded Generics, Which One You Prefer to Prescribe?
by: Manjunath Premanath, et al.
Published: (2024)

Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives
by: M Venkatesh, et al.
Published: (2011)

HOW RATIONAL ARE DRUGS USED IN MALAYSIAN PRIMARY HEALTH CARE SECTOR?
by: MOHAMED IZHAM MOHAMED IBRAHIM, et al.
Published: (2006)

Effect of Patients' Attitude on their Satisfaction and Switching Intention in Generic Medicine Industry: An Empirical Analysis in India
by: Bibekananda Mohanty, et al.
Published: (2022)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
by: Ping Yang, et al.
Published: (2021)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015)

The Portuguese generic medicines market: A policy analysis.
by: Simoens S
Published: (2009)

Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018)

Generics and biosimilars in oncology
by: I. A. Gopienko, et al.
Published: (2020)

Impact of Generic Entry on Hospital Antimicrobial Use: A Retrospective Quasi-Experimental Interrupted Time Series Analysis
by: Mercè Espona, et al.
Published: (2021)

DEVELOPING GENERIC COMPETENCES OUTSIDE THE UNIVERSITY CLASSROOM
by: Azucena Barahona Mora
Published: (2018)

Generic Drug Product Development Bioequivalence Issues
by: Iain J. McGilveray
Published: (2008)

Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety
by: Alexandra Thoenes, et al.
Published: (2020)

The Brazilian private pharmaceutical market after the first ten years of the generics law
by: Andréa Dâmaso Bertoldi, et al.
Published: (2019)

Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers
by: Priya Jayachandran
Published: (2023)

Are doctor of pharmacy curricula in developing countries adequate to train graduates to provide pharmaceutical care?
by: Ramalingam Peraman, et al.
Published: (2017)

Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014
by: Andréa Dâmaso Bertoldi, et al.